Cargando…

Factor XI, a potential target for anticoagulation therapy for venous thromboembolism

Venous thromboembolism (VTE) is a common cause of mortality and disability in hospitalized patients, and anticoagulation is an essential therapeutic option. Despite the increasing use of direct oral anticoagulants, complications and adverse drug reactions still occur in patients with VTE. Within 5 y...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Tingting, Liu, Jiang, Wu, Weihua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659736/ https://www.ncbi.nlm.nih.gov/pubmed/36386334 http://dx.doi.org/10.3389/fcvm.2022.975767

Ejemplares similares

Association Between Anticoagulation Outcomes and Venous Thromboembolism History in Chronic Thromboembolic Pulmonary Hypertension
por: Zhu, Yong-Jian, et al.
Publicado: (2021)

Factor XI Inhibitors for Prevention and Treatment of Venous Thromboembolism: A Review on the Rationale and Update on Current Evidence
por: Nopp, Stephan, et al.
Publicado: (2022)

Preeclampsia and Venous Thromboembolism: Pathophysiology and Potential Therapy
por: Raia-Barjat, Tiphaine, et al.
Publicado: (2022)

Venous Thromboembolism in Cancer: An Update of Treatment and Prevention in the Era of Newer Anticoagulants
por: Qureshi, Waqas, et al.
Publicado: (2016)

Patient Characteristics and Preferences Regarding Anticoagulant Treatment in Venous Thromboembolic Disease
por: Lanéelle, Damien, et al.
Publicado: (2021)

Assessment of bleeding risk in cancer patients treated with anticoagulants for venous thromboembolic events
por: Poénou, Géraldine, et al.
Publicado: (2023)

Shorter or longer anticoagulation to prevent recurrent venous thromboembolism: systematic review and meta-analysis
por: Lopes, Luciane Cruz, et al.
Publicado: (2014)

Factors XI and XII as Targets for New Anticoagulants
por: Weitz, Jeffrey I., et al.
Publicado: (2017)

Editorial: Venous thromboembolism and pregnancy
por: Tardy, Bernard, et al.
Publicado: (2022)

Net Clinical Benefit of Direct Oral Anticoagulants in Patients With Cancer and Venous Thromboembolism: A Systematic Review and Trade-Off Analysis
por: Yan, Yi-Dan, et al.
Publicado: (2020)

Venous Thromboembolism Risk Score and Pregnancy
por: Raia-Barjat, Tiphaine, et al.
Publicado: (2022)

Editorial: COVID-19 and Venous Thromboembolism
por: Yamashita, Yugo
Publicado: (2021)

Differential Presentations of Arterial Thromboembolic Events Between Venous Thromboembolism and Atrial Fibrillation Patients
por: Lin, Yu-Sheng, et al.
Publicado: (2021)

Protein S Deficiency and the Risk of Venous Thromboembolism in the Han Chinese Population
por: Wu, Yingying, et al.
Publicado: (2022)

Clinical epidemiology of venous thromboembolic disease: An institutional registry
por: AlSheef, Mohammed, et al.
Publicado: (2022)

Blood Cells and Venous Thromboembolism Risk: A Two-Sample Mendelian Randomization Study
por: He, Jiahao, et al.
Publicado: (2022)

Bleeding and thrombotic complications during treatment with direct oral anticoagulants or vitamin K antagonists in venous thromboembolic patients included in the prospective, observational START2-register
por: Palareti, Gualtiero, et al.
Publicado: (2020)

Preventing Postpartum Venous Thromboembolism in 2022: A Narrative Review
por: Blondon, Marc, et al.
Publicado: (2022)

Hypercholesterolemia and COVID-19: Statins for Lowering the Risk of Venous Thromboembolism
por: Vuorio, Alpo, et al.
Publicado: (2021)

Impact of Age, Sex, and Renal Function on the Efficacy and Safety of Direct Oral Anticoagulants vs. Vitamin K Antagonists for the Treatment of Acute Venous Thromboembolism: A Meta-Analysis of 22,040 Patients
por: Zhou, Bo, et al.
Publicado: (2021)

Current Trends in the Duration of Anticoagulant Therapy for Venous Thromboembolism: A Systematic Review
por: Alexander, Peter, et al.
Publicado: (2021)

Predictors of pregnancy-associated venous thromboembolism: A case-control study
por: Alsheef, Mohammed A., et al.
Publicado: (2022)

ThromboprophylaXIs with Factor XI/XIa inhibitors for venous thromboembolism
por: Porres-Aguilar, Mateo
Publicado: (2023)

Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF)
por: Rohla, Miklos, et al.
Publicado: (2019)

The incidence and risk of venous thromboembolism associated with peripherally inserted central venous catheters in hospitalized patients: A systematic review and meta-analysis
por: Puri, Anju, et al.
Publicado: (2022)

Development and Validation of a Risk Prediction Model for Venous Thromboembolism in Lung Cancer Patients Using Machine Learning
por: Lei, Haike, et al.
Publicado: (2022)

Varicose Veins and Risk of Venous Thromboembolic Diseases: A Two-Sample-Based Mendelian Randomization Study
por: Li, Ruihao, et al.
Publicado: (2022)

FRI111 Venous Thromboembolism In Cushing Syndrome - A Call For Standardized Anticoagulation Regimen In Hypercortisolism
por: Minasyan, Mari, et al.
Publicado: (2023)

Statin treatment and risk of recurrent venous thromboembolism: a nationwide cohort study
por: Nguyen, Cu Dinh, et al.
Publicado: (2013)

Epidemiology of venous thromboembolism in Africa: a systematic review and meta-analysis protocol
por: Danwang, Celestin, et al.
Publicado: (2017)

Long-Term Survival After Venous Thromboembolism: A Prospective Cohort Study
por: Nilius, Henning, et al.
Publicado: (2021)

Association of Gonadotropin-Releasing Hormone Therapies With Venous Thromboembolic Events in Patients With Prostate Cancer: A National Cohort Study
por: Hong, Chon-Seng, et al.
Publicado: (2022)

Current Knowledge on Factor V Leiden Mutation as a Risk Factor for Recurrent Venous Thromboembolism: A Systematic Review and Meta-Analysis
por: Eppenberger, Daria, et al.
Publicado: (2022)

Comparison of long-term complications in cancer patients with incidental and acute symptomatic venous thromboembolism
por: Barca-Hernando, María, et al.
Publicado: (2023)

The association of statin use with reduced incidence of venous thromboembolism: a population-based cohort study
por: Lassila, Riitta, et al.
Publicado: (2014)

Body size measures and risk of venous thromboembolism: protocol for a systematic review and meta-analysis
por: Kaze, Arnaud D, et al.
Publicado: (2018)

Prevalence of Venous Thromboembolism in Critically Ill COVID-19 Patients: Systematic Review and Meta-Analysis
por: Mohamed, Mouhand F. H., et al.
Publicado: (2021)

Risk and timing of venous thromboembolism in patients with gastrointestinal cancer: a nationwide Danish cohort study
por: Tønnesen, Jacob, et al.
Publicado: (2023)

Predicting Recurrent Venous Thromboembolism in Patients With Deep-Vein Thrombosis: Development and Internal Validation of a Potential New Prediction Model (Continu-8)
por: Nagler, Michael, et al.
Publicado: (2021)

Sodium alginate-hydrogel coatings on extracorporeal membrane oxygenation for anticoagulation
por: Gao, Wenqing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f8fqefv1dhbjsfhoo714jsunmk